Preferential amplification and molecular characterization of junction sequences of a pathogenetic deletion in human mitochondrial DNA.
Deletions of mitochondrial DNA have been detected in skeletal muscle of some patients with mitochondrial encephalomyopathies, but their junctions have been defined only approximately. We developed a procedure, using widely spaced primers for the polymerase chain reaction, that amplifies preferentially the sequences bracketing the deletion. This procedure permits detection of minor proportions, not detectable by Southern analysis, of deleted mitochondrial DNA species in a heteroplasmic mixture. Different proportions of intact mitochondrial DNA and species deleted from nucleotide 8708 to 13,722 were found in skeletal muscle, blood, and urinary epithelial cells from a patient with chronic progressive external ophthalmoplegia. These data indicate that the mutation occurred at or before early embryonic development and provide the first definition at the nucleotide level of a human disease caused by a deletion of mitochondrial DNA.
Johns
D R
DR
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Hurko
O
O
D000251:Adenosine Triphosphatases / Q000235:genetics; D000328:Adult; D001483:Base Sequence; D015139:Blotting, Southern; D004272:DNA, Mitochondrial / Q000097:blood / Q000235:genetics* / Q000652:urine; D005260:Female; D005784:Gene Amplification; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data; D009132:Muscles / Q000378:metabolism; D009154:Mutation; D009245:NADH Dehydrogenase / Q000235:genetics; D009886:Ophthalmoplegia / Q000235:genetics*
D004272:DNA, Mitochondrial; D009245:NADH Dehydrogenase; D000251:Adenosine Triphosphatases